Alisha Heather Bent, Christine Parseghian, Van K. Morris, Victoria Higbie, Madhulika Eluri, Bryan K. Kee, Ryan W. Huey, Jason Willis, Maria Pia Morelli, S. Daniel Haldar, Salvador Alonso Martinez, John Paul Y.C. Shen, Kanwal Pratap Singh Raghav, Michael J. Overman, Kalyna Horodecky, Kristin Alfaro, Kathryn Aziz, Robert J. Kell, Scott Kopetz, Arvind Dasari. "A phase 2 trial of TAS-102 with or without celecoxib in ctDNA-defined minimal residual disease (MRD) in colorectal cancer after completion of adjuvant chemotherapy.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.tps270